Insider · CIK 0001723174
ARCH Venture Partners IX, LLC
owner
Files at LYEL (Lyell Immunopharma, Inc.). First filing Mar 9, 2026, latest Mar 9, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$12M bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LYEL: Lyell Immunopharma, Inc.
LYELOct 9, 2026 · close 8.71
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Lyell Immunopharma, Inc. | $12M 488,090 shares | +52% | +188% from low-42% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | LYEL Lyell Immunopharma, Inc. | POpen-market purchase Common Stockindirect: See footnote | +488,090 | $25.61 | $12M | 1,426,528 | Mar 9, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.